Clinical Trials in Dallas

Showing 12141-12160 of 17,468 trials

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and thalidomide in treating patients who have recurrent or progressive brain tumor.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 participantsStarted Jun 2000

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

NCT00132301

VA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for patients who are potentially cured by radical prostatectomy but who are at high risk for relapse. The standard of care is surveillance, with the addition of androgen deprivation at the time of biochemical relapse. This study will assess the effect of adding early chemotherapy to the standard of care on progression free survival in Veterans at high risk for progression after prostatectomy.

Prostate Cancer

VA Office of Research and Development298 participantsStarted Jun 2006

Birmingham, Alabama, United States • Tucson, Arizona, United States • North Little Rock, Arkansas, United States +31 more locations

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

Find Trials by Condition in Dallas

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Clinical Performance Comparison of Two Contact Lenses

Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Vistakon Investigational Multi-purpose Contact Lens Care Solution.

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Evaluation of Etafilcon A Daily Disposable Lenses

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease